Living | Page 59 of 70

Sanofi-aventis and UCSF to Collaborate on Development of Diabetes Therapies

The University of California, San Francisco (UCSF) and sanofi-aventis have formed two new research and development collaborations that join together leaders from academia and industry to more rapidly advance groundbreaking innovation from the lab to the patient. The first collaboration promotes innovative research in pharmacological science and in multiple therapeutic areas, such as oncology, aging, diabetes and inflammation...

Eli Lilly and Boehringer Ingelheim to Develop and Market New Diabetes Drugs

Eli Lilly and Company and Boehringer Ingelheim announced a global agreement to jointly develop and commercialize a portfolio of diabetes compounds currently in mid- and late-stage development. Included are Boehringer Ingelheim's two oral diabetes agents—linagliptin and BI10773—as well as Lilly's two basal insulin analogues—LY2605541 and LY2963016—as well as the option to co-develop and co-commercialize Lilly's anti-TGF-beta monoclonal antibody....

Haiti’s Diabetics One Year After The Earthquake

During the earthquake, 90 percent of diabetes patients lost their medication. However, under the leadership of International Diabetes Federation (IDF) and diabetes associations worldwide...

Best Diabetes Tearjerkers, The Most Moving Blog Posts of 2010

I was hallucinating with a blood sugar hovering around 20 mg/dl. We fixed it with Welch’s grape juice and sat in the living room listening to the ocean...

Sanofi-aventis Acquires Next Generation Drug Delivery Technology for Diabetes Treatment

Sanofi-aventis announced it has signed a global licensing and patent transfer agreement with Ascendis Pharma (Ascendis) on Ascendis’ proprietary TransCon Linker and Hydrogel carrier technology, which allows for a drug compound to be released in the body in a precise, time-controlled fashion, creating a long-acting effect...

An Interview With Charlie Kimball, The World’s Fastest Diabetic

I’m a better athlete because of my diabetes rather than despite it. I’m more aware of my body and proactive about my health...

Charlie Kimball, Type 1 Diabetic, To Pilot New IndyCar Entry

Novo Nordisk announced today that it has joined Chip Ganassi Racing to create the Novo Nordisk Chip Ganassi Racing team for the 2011 IZOD IndyCar season. The team will sponsor a new entry in the series driven by American racecar driver and type 1 diabetic, Charlie Kimball...

Novo Nordisk to Sponsor Diabetes Leadership Forum in Dubai

The Middle East and Northern Africa (MENA) region is facing one of the greatest healthcare challenges of our time: the diabetes pandemic. It is estimated that 26.6 million people in the region have diabetes and this number is set to double to 51.7 million by 2030. To help find solutions to this challenge, Novo Nordisk is sponsoring a Diabetes Leadership Forum on 12-13 December in Dubai. At the Forum, a group of over 600 regional...

A Powerlifter’s Mind in a Type 1 Body

I no longer view counting carbohydrates as a diabetic obligation, but instead a responsibility I take on to ensure I’m fueled for my powerlifting training...

Seeking Stability

The place where instability shows up, not as a feeling, but as something concrete, is in my blood sugar numbers.